- Home
- ZUMZ vs ALMS Comparison
ZUMZ vs ALMS Comparison
Compare ZUMZ & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- ALMS
- Stock Information
- Founded
- ZUMZ 1978
- ALMS 2021
- Country
- ZUMZ United States
- ALMS United States
- Employees
- ZUMZ N/A
- ALMS N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- ALMS
- Sector
- ZUMZ Consumer Discretionary
- ALMS
- Exchange
- ZUMZ Nasdaq
- ALMS NYSE
- Market Cap
- ZUMZ 401.1M
- ALMS 469.0M
- IPO Year
- ZUMZ 2005
- ALMS 2024
- Fundamental
- Price
- ZUMZ $15.47
- ALMS $7.66
- Analyst Decision
- ZUMZ Hold
- ALMS Strong Buy
- Analyst Count
- ZUMZ 2
- ALMS 6
- Target Price
- ZUMZ $22.00
- ALMS $29.60
- AVG Volume (30 Days)
- ZUMZ 288.2K
- ALMS 122.0K
- Earning Date
- ZUMZ 03-13-2025
- ALMS 02-15-2025
- Dividend Yield
- ZUMZ N/A
- ALMS N/A
- EPS Growth
- ZUMZ N/A
- ALMS N/A
- EPS
- ZUMZ N/A
- ALMS N/A
- Revenue
- ZUMZ $891,864,000.00
- ALMS N/A
- Revenue This Year
- ZUMZ $4.32
- ALMS N/A
- Revenue Next Year
- ZUMZ $2.19
- ALMS N/A
- P/E Ratio
- ZUMZ N/A
- ALMS N/A
- Revenue Growth
- ZUMZ 2.07
- ALMS N/A
- 52 Week Low
- ZUMZ $12.90
- ALMS $6.75
- 52 Week High
- ZUMZ $31.37
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- ZUMZ 29.16
- ALMS N/A
- Support Level
- ZUMZ $15.18
- ALMS N/A
- Resistance Level
- ZUMZ $19.64
- ALMS N/A
- Average True Range (ATR)
- ZUMZ 0.85
- ALMS 0.00
- MACD
- ZUMZ -0.30
- ALMS 0.00
- Stochastic Oscillator
- ZUMZ 6.16
- ALMS 0.00
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.